small molecule

ANTIZOL

FOMEPIZOLE

Loss of exclusivityJune 2027latest FDA-listed patent expiry
CompanyParView the full company profile on CliffBio

Drug detail

Brand nameANTIZOL
Active ingredientFOMEPIZOLE
Strength1.5GM/1.5ML (1GM/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalDecember 1997
Marketing statusDISCN

Listed patents

PatentExpiresType
7553863June 2027substance, product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ANTIZOL patent cliff — loss of exclusivity June 2027 | CliffBio